Trials that use: Negative binomial regression
New to this method? Read the tutorial →
226 results
- Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria: primary endpoint results, effect estimate with confidence…
- Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes: primary…
- Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Efficacy of Polyethylene Glycol-Interferon Alfa-2B (PEG-Intron, SCH 54031) Compared to Interferon Alfa-2B in Participants With Chronic Hepatitis C (MK-4031-016): Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Polyethylene Glycol-Interferon Alfa-2B (PEG-Intron, SCH 54031) Compared to Interferon Alfa-2B in Participants With Chronic Hepatitis C (MK-4031-016): primary endpoint results, effect estimate with confidence interval, sample-size…
- Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00730691).
- Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to…
- Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Efficacy, Tolerability, and Safety Study of DFN-15: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Tolerability, and Safety Study of DFN-15: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03006276).
- Emotion Regulation Interventions for Alcohol-Related Sexual Aggression: Complete Statistical AnalysisIndependent statistical analysis of Emotion Regulation Interventions for Alcohol-Related Sexual Aggression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03159468).
- EMPACT-MIIndependent statistical analysis of EMPACT-MI, the randomized, placebo-controlled phase 3 trial of empagliflozin 10 mg after myocardial infarction: covariate-adjusted Cox hazard ratio for heart failure hospitalisation or death, negative binomial rate ratios…
- EPIC-SRIndependent statistical analysis of EPIC-SR (NCT05011513), the randomized, placebo-controlled phase 2/3 trial of nirmatrelvir plus ritonavir in standard-risk COVID-19, covering the log-rank primary analysis, logistic-regression odds ratios, negative binomial modelling and serious…
- EREPIndependent statistical analysis of Emotion Regulation and Emotion Perception: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03790878).
- Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluation of Efficacy of Experimental Gel to Foam Dentifrices in Dental Erosion: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Efficacy of Experimental Gel to Foam Dentifrices in Dental Erosion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluation of Green Dot a Primary Prevention Intervention: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Green Dot a Primary Prevention Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01878097).
- Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Evaluation of Robotic Arm Rehabilitation in Stroke Patients: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Robotic Arm Rehabilitation in Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00333983).
- Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- EW-DIndependent statistical analysis of A Community Wellness Program for Adults Living With Long-term Physical Disability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model: Complete Statistical AnalysisIndependent statistical analysis of Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00752089).
- FAME 3Independent statistical analysis of A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease: primary endpoint results, effect estimate with…
- Fatty Acid Oxidation Defects and Insulin Sensitivity: Complete Statistical AnalysisIndependent statistical analysis of Fatty Acid Oxidation Defects and Insulin Sensitivity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02517307).
- FIGARO UC 303Independent statistical analysis of An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896): Complete Statistical AnalysisIndependent statistical analysis of Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- FLOREYIndependent statistical analysis of Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FREEDOMS IIIndependent statistical analysis of Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GALAComplete statistical analysis of the phase 3 GALA trial of glatiramer acetate 40 mg three times weekly versus placebo in relapsing-remitting multiple sclerosis, including trial design, relapse endpoints, MRI outcomes, statistical methodology,…
- GALATHEAIndependent statistical analysis of the phase 3 GALATHEA trial of benralizumab 30 mg and 100 mg versus placebo in moderate to very severe COPD with exacerbation history, covering negative binomial exacerbation-rate ratios,…
- Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02170870).
- Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: Complete Statistical AnalysisIndependent statistical analysis of Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GLEAMIndependent statistical analysis of A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME): primary endpoint results, effect estimate with confidence…
- GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00950807).
- Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis: Complete Statistical AnalysisIndependent statistical analysis of Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01654549).
- Hemodynamic Effects of Compression in POTS: Complete Statistical AnalysisIndependent statistical analysis of Hemodynamic Effects of Compression in POTS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03484273).
- IMAGEIndependent statistical analysis of A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- JUNIPERIndependent statistical analysis of Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- LIBERTY ASTHMA QUESTAn independent statistical analysis of the phase 3 LIBERTY ASTHMA QUEST trial of dupilumab 200 mg and 300 mg every two weeks versus matched placebo in persistent asthma, covering negative binomial rate…
- LIDSIndependent statistical analysis of A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LOUiSSeIndependent statistical analysis of A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome: primary endpoint results, effect estimate with confidence interval,…
- MAHALEIndependent statistical analysis of Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MANDALAA detailed statistical analysis of the phase 3 MANDALA trial of budesonide/albuterol metered-dose inhalers versus albuterol in adults and children 4 years of age or older with asthma, including time-to-event, rate, binary,…
- MATINEEAn independent statistical analysis of the phase 3 MATINEE trial of mepolizumab 100 mg versus placebo in COPD with frequent exacerbations and raised eosinophil levels, covering the negative binomial exacerbation-rate analysis, Cox…
- NAVIGATORIndependent statistical analysis of the phase 3 NAVIGATOR trial (NCT03347279) of tezepelumab 210mg Q4W versus placebo in severe uncontrolled asthma: negative binomial exacerbation rate ratios, mixed-model secondary endpoints, safety and interpretation.
- NEOSURFIndependent statistical analysis of Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…